You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Advancing a Candidate Human Polyclonal Anti-Thymocyte Globulin Product Produced in Transchromosomal Bovine for Transplant Induction/Acute Rejection and T1D Therapy
SBC: SAB Biotherapeutics, Inc. Topic: NIAIDProject Summary Abstract Currently available anti thymocyte globulinATGproducts are polyclonal animal antibodiesATGAMequine polyclonal ATGThymoglobulinrabbit polyclonal ATGand have found broad use as immune tolerizing agentsparticularly for induction therapy in a majority of tissue transplantsfor acute transplant rejectionand as treatment for graft vshost disease following bone marrow transplantsE ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Discovery of NaV1.7 Inhibitors for the Treatment of Pain
SBC: SITEONE THERAPEUTICS, INC. Topic: 105PROJECT SUMMARY The objective of our program is to develop a safe and effective nonopioid analgesic for the treatment of neuropathic pain, such as pain associated with chemotherapy-induced peripheral neuropathy, that targets an isoform of the voltage-gated sodium ion channel, NaV1.7. Voltage-gated sodium channels are involved in the transmission of nociceptive signals from their site of origin in ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Acoustic Enhanced Cell Culture
SBC: RESODYN CORPORATION Topic: 400This Small Business Innovation Research Phase I project will develop a prototype and then evaluate a novel device that utilizes low frequency sound energy to enhance cell culture productivityThe acoustic micromixing generated by the proposed device is compatible with cells and possesses the capability to substantially enhance the culture efficiency of cells cultured in typical culture vesselsThis ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Development of NaV1.7 Inhibitors for the Treatment of Chronic Cough
SBC: SITEONE THERAPEUTICS, INC. Topic: NHLBIPROJECT SUMMARYThe objective of our program is to develop a safe and effective therapeutic for chronic coughChronic coughor cough that persists for more than eight weeksis a condition that is often associated with diseases such as chronic obstructive pulmonary disorderCOPDasthmaidiopathic pulmonary fibrosisbronchiectasis or gastroesophageal reflux diseaseGERDIn other casesthe etiology is unknownCh ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Topical selective T-type blockers for the treatment of pruritus
SBC: DERMAXON LLC Topic: NIAMSProject SummaryAbstractPruritusalso called itchis the most frequent dermatological symptom in the US with up toof Americans being affectedPruritic stimuli are detected by a subset of nociceptive neuronspruriceptorswhich fire action potential in response to peripheral activation by THor THmolecules induced by chronic inflammatory skin diseases such as ichthyosisprurigo nodularisand hidradenitis sup ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Project isoPTE: isothermic post-traumatic epilepsy miRNA biomarker detection
SBC: FYR Diagnostics, LLC Topic: 999Project Summary Acquired epilepsy results from acute brain injury, such as traumatic brain injury (TBI). Acquired epilepsy is a major public health issue with inadequate treatment and diagnostic options. There are no biomarkers that assist in the prediction or diagnosis of acquired epilepsy. Project isoPTE will use two animal models of epilepsy to determine whether plasma microRNA (miRNA) biomarke ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
An optimized screening platform for identifying and quantifying biased agonists as drugs for the treatment of Opioid Use Disorder
SBC: MONTANA MOLECULAR LLC Topic: NIDA! Project Summary Millions of Americans today have an opioid use disorderOUDMillions more misuse opioidsand the crisis continues to growThe goal of this proposal is to speed the discovery of non addictive analgesics by providing drug discovery teams with simplermore robustmore quantitativeassays for agonist biasDriven by the urgency of the problem we are seeking Fast Track support to create new as ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Developing EXP-1801 as an imaging agent to quantify pain and analgesia
SBC: Expesicor Inc Topic: NINDSSummary Abstract There are currently no tools available that can objectively measure painHistoricallypain in humans has been measured using subjective ratings to determine presence and severityIn animal modelspain is measured by semi quantitative assays that rely on the observation of pain behaviorsThough usefulthe inherently subjective nature of these measures has hampered both research and treat ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Modeling drug-refractory epilepsy with the KaL method
SBC: Expesicor Inc Topic: NINDSEpilepsy is a common neurological disorder that is characterized by recurrentspontaneousseizuresEpilepsy is a major public health issue with inadequate treatment optionsOvermillion people worldwide have epilepsyThis is more than cerebral palsymultiple sclerosisandParkinson s disease combinedAlthough more than two dozen antiseizure drugsASDsexistapproximately one third of patientsovermillionsuffer ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health